Objective-Apoptosis is a key feature of advanced atherosclerotic plaques. Attraction signals such as p43 released from apoptotic cells play a crucial role in the timely removal of the apoptotic remnants by recruiting fresh phagocytes. Here, we sought to determine whether p43 may link apoptosis to inflammation and plaque progression. Methods and Results-RT-PCR and immunohistochemistry showed that p43 was abundantly expressed in human plaques compared with nonatherosclerotic mammary arteries and colocalized with splicing factor SC-35. Cell culture experiments indicated that p43 expression was associated with enhanced protein translation. On initiation of apoptosis or necrosis, p43 was cleaved by calpains and released as truncated protein p43(apoptosis-released factor [ARF]). Processing of p43 into endothelial monocyte activating polypeptide II was not observed. Full-length p43, but not p43(ARF) or endothelial monocyte activating polypeptide II, activated THP1 monocytes (upregulation of tumor necrosis factor ␣, interleukin 1␤, interleukin 8, macrophage inflammatory protein (MIP)-1␣, MIP1␤, MIP2␣) and endothelial cells (enhanced synthesis of E-selectin, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, tissue factor). The chemotactic activity of p43 or fragments thereof was poor compared with ATP. Treatment of smooth muscle cells with p43 did not induce cell death. Conclusion-p43 is cleaved during apoptosis by calpains and released as a truncated protein that is harmless for the structure of the plaque. (Arterioscler Thromb Vasc Biol. 2010;30:1415-1422.) 
A poptosis is a major event in the progression of atherosclerosis and has been described for various cell types in the plaque. 1, 2 The organelles and plasma membrane of apoptotic cells typically remain intact, avoiding proinflammatory spilling of the cellular content into the surrounding tissue. In this light, apoptosis has long been considered immunologically silent. However, recent evidence suggests that inflammatory and apoptotic processes in atherosclerosis are closely intertwined and that apoptosis may actually promote inflammation. 3 Indeed, apoptotic cells release proinflammatory cytokines and chemotactic factors that serve as attraction or "find-me" signals. 3 Among them, p43 (also known as small inducible cytokine subfamily E member 1) has been shown to actively stimulate phagocyte chemotaxis. 4 Apart from its proinflammatory role, p43 exhibits a broad spectrum of other biological functions related to atherosclerosis, such as induction of vasodilation, upregulation of adhesion molecules by endothelial cells, and manipulation of the procoagulant properties of these cells, likely through upregulation of tissue factor. 5 In addition, p43 is known to be identical to the p43 subunit of the mammalian tRNA multisynthetase complex and is assumed to function as a cofactor during translation. 6 The N-terminal domain of p43 interacts with an N-terminal extension of arginyl-tRNA synthetase, 7 whereas the C-terminal domain contains an RNA binding motif that can interact with different tRNAs, 8 suggesting that p43 facilitates aminoacylation by delivering tRNA to the active site of an associated arginyl-tRNA synthetase. Alternatively, p43 may play a role in tRNA transport in part because it is a homolog of the putative yeast tRNA shuttle protein Arc1p and because export of mature eukaryotic tRNAs requires aminoacylation. 9 Despite its proinflammatory effects, there is little sequence homology with other human or mouse proteins, such as cytokines or chemokines. It is homologous, however, to the C-terminal regions of methionyl-tRNA synthetases in prokaryotes, archaeas, and nematodes, as well as to human tyrosyl-tRNA synthetase. 6, 10 p43 is synthesized as a 34-kDa precursor molecule that is proteolytically cleaved into endothelial monocyte activating polypeptide II (EMAP II; 18 kDa) under conditions of cellular stress. 11, 12 Behrensdorf et al 13 reported that caspase-7 is capable of cleaving p43 and that the release of EMAP II by apoptotic cells may provide a mechanism for leukocyte recruitment to sites of programmed cell death. It should be noted that these findings were made in in vitro cleavage assays with recombinant mouse proteins. Experiments with human proteins showed that p43 is not cleaved by caspases and that EMAP II could not be found in apoptotic cells. 14 Furthermore, it remains unclear whether EMAP II or its precursor is the real cytokine. 4, 15 To make the situation even more complex, Shalak et al 16 have characterized a novel 22.5-kDa p43 intermediate with largely unknown function that was rapidly released from apoptotic cells and therefore referred to as an apoptosis-released factor, p43(apoptosisreleased factor [ARF]). Given that p43 is present in advanced human plaques 15 and that apoptosis is a main feature of such lesions, 1,2 the aim of the present study was to determine whether p43 (or derivatives) may link apoptosis to inflammation and plaque progression.
Methods
The Methods section is available online at http://atvb.ahajournals.org.
Results p43 Is Overexpressed in Human Atherosclerotic Plaques
Real-time RT-PCR showed a 5.2Ϯ1.0-fold upregulation of p43 mRNA expression in human carotid endarterectomy specimens (nϭ6) as compared with nonatherosclerotic mammary arteries (nϭ6). In addition to p43 mRNA, we observed a marked expression of p43 protein in the plaque, most notably in the macrophage-rich layer around the necrotic core ( Figure 1A ). The p43 protein was found not only in the monocyte/macrophage population of the plaque but also in smooth muscle cells (SMCs) ( Figure 1B ) and in endothelial cells of microvessels ( Figure 1C ). Because the localization of p43 in SMCs was solely based on morphological criteria, we also combined immunodetection of p43 with a periodic acid Schiff stain. SMCs, particularly those in the fibrous cap, are surrounded by a cage of periodic acid Schiff-positive basal lamina and stained positive for p43 (Supplemental Figure IA , available online). SMCs from the normal medium adjacent to carotid plaques ( Figure 1D ) or SMCs in mammary arteries (not shown) showed limited expression of p43 protein. To confirm p43 expression in macrophages, serial sections of carotid plaques were immunohistochemically stained for p43 and the macrophage marker CD68. By using this approach, we found that p43 colocalized with CD68-positive areas of the plaque (Supplemental Figure IB) . Cell culture experiments showed that p43 expression was not significantly different in M1 macrophages as compared with resting macrophages but was downregulated in M2 macrophages (Supplemental Figure II) . Western blotting of crude lysates from different carotid plaques revealed that p43 was predominantly expressed as a full-length protein ( Figure 1E ). However, we also detected variable amounts of p43(ARF). Besides human plaques, p43 was also abundantly present in plaques from apolipoprotein E Ϫ/Ϫ mice fed a Western-type diet (Supplemental Figure III ).
p43 Expression Is Associated With Enhanced Protein Synthesis
Because p43 is identical to an auxiliary protein of the aminoacyl tRNA synthetase complex, 6 we assumed that overexpression of p43 in atherosclerosis is associated with protein translation. Immunohistochemical staining of carotid plaques for p43 and splicing factor SC-35 showed that these proteins colocalized (Figure 2A ), even though p43 was found in the cytoplasm and SC-35 in the nucleus. Cells negative for p43 were also SC-35 negative ( Figure 2B ). Human monocytic THP1 cells showed high levels of p43 protein and mRNA as compared with CD14 ϩ primary blood monocytes, which corresponded to their capacity of protein synthesis ( Figure  2C ). Stimulation of protein synthesis in CD14 ϩ monocytes with LPS upregulated p43 expression ( Figure 2D ). Given that protein synthesis is downregulated in apoptotic cells, we hypothesized that p43 does not colocalize with apoptotic cell death. Indeed, serial sections of carotid plaques stained for apoptotic cells (TUNEL) or p43 did not reveal an association between apoptosis and p43 expression (Supplemental Figure IV ).
p43 Is Cleaved Into p43(ARF) After Induction of Cell Death
Because maturation of p43 into mature EMAP II has been associated with apoptosis, 11, 13 the processing and release of p43 or fragments thereof were examined in human monocytic THP1 cells undergoing cell death. In standard RPMI medium supplemented with 10% fetal bovine serum, THP1 cells showed intracellular expression of p43 and a proteolytic intermediate ( Figure 3A ). Other intermediates, such as p43(ARF) or EMAP II, could not be detected or were present in trace amounts. Neither p43 nor one of the proteolytic fragments was secreted in the culture medium. However, p43 was cleaved into p43(ARF) and released in the extracellular medium during serum deprivation. Serum-deprived THP1 cells underwent apoptosis and postapoptotic necrosis, as shown by cleavage of caspase-3 and extracellular accumulation of lactate dehydrogenase, respectively ( Figure 3B ). Also the nitric oxide donor spermine NONOate, a well-known inducer of apoptosis in monocytes/macrophages, 17 readily induced apoptosis and postapoptotic necrosis, similar to serum deprivation, and led to cleavage of p43 into p43(ARF) ( Figure 3C ). Western blotting of crude lysates at different time points indicated that p43(ARF) was released into the culture medium when cells became necrotic. Treatment of THP1 cells with nigericin induced necrosis, as previously described, 18 and triggered the release of both p43 and p43(ARF) ( Figure 3D ). Moreover, 7-ketocholesterol, which is one of the primary cytotoxins of oxidized low-density lipoprotein, yielding a complex mode of cell death in atherosclerotic plaques, 19 led to p43(ARF) formation ( Figure 3E ). EMAP II was not detected, unless in very low amounts. In addition to THP1, primary human CD14 ϩ monocytes, human aortic SMCs, or human umbilical vein endothelial cells (HUVECs) undergoing puromycin-or 7-ketocholesterolinduced cell death showed cleavage of p43 in p43(ARF) followed by the release of this proteolytic intermediate in the culture supernatant (Supplemental Figure V) , indicating that formation of p43(ARF) is not cell-type specific.
Calpain I Is Responsible for p43(ARF) Formation
To identify the protease that is responsible for p43(ARF) formation, p43 was expressed in Escherichia coli and purified. Although previous studies had suggested that caspase-7 and elastase are potential p43 processing enzymes, 13, 16 neither caspase-3 nor caspase-7 was capable of cleaving purified p43 ( Figure 4A ). In contrast, elastase fully degraded p43 ( Figure 4B ). We therefore followed an alternative strategy to characterize the p43 processing enzyme and treated THP1 cells with nigericin in the presence of protease inhibitors. Among 14 different compounds tested, only antipain and leupeptin inhibited p43(ARF) formation without affecting necrosis induction (release of lactate dehydrogenase) ( Figure  4C ). Given that both antipain and leupeptin are potent calpain inhibitors, THP1 cells were treated with nigericin in the presence of the calpain-specific protease inhibitor PD150606. This compound inhibited p43(ARF) formation ( Figure 4D ), similar to antipain or leupeptin. Treatment of p43 with calpain-1 yielded a polypeptide of Ϸ26 kDa, comigrating with recombinant p43(ARF) ( Figure 4E ). The N-terminal amino acid sequence, SGTKEQ, of the polypeptide recovered after calpain digestion was determined by Edman degradation and corresponded to the N terminus of p43(ARF).
p43 but Not p43(ARF) or EMAP II Activates THP1 Cells and HUVECs
THP1 and HUVEC cells showed hyperphosphorylation of IB␣ after treatment with p43 ( Figures 5A and 6A) , indicative of nuclear factor-B activation, but did not reveal hyperphosphorylation of the mitogen-activated protein kinases p38, extracellular signal-regulated kinase-1/2 (ERK1/2), or c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) (not shown). Neither p43(ARF) nor EMAP II was able to stimulate IB␣ phosphorylation in THP1 ( Figure  5A ) or HUVECs ( Figure 6A ). Hyperphosphorylation of IB␣ in THP1 was associated with enhanced mRNA transcription of the cytokines tumor necrosis factor (TNF) ␣, interleukin (IL) 1␤, and IL8, as well as the chemokines macrophage inflammatory protein (MIP)-1␣, MIP1␤, and MIP2␣ ( Figure  5B ). Enhanced secretion of TNF␣ and MIP1␣ by p43-treated THP1 was confirmed at the protein level via ELISA ( Figure  5C ). Because it has been suggested that EMAP II has chemotaxis activity to promote clearance of dead cells, 4 we then determined whether p43 or its fragments were able to attract THP1 cells in a transwell migration assay. p43 or fragments thereof did not significantly attract THP1 cells, although ATP, one of the main chemotactic factors released by apoptotic cells, 20 induced massive monocyte recruitment ( Figure 5D ). In HUVECs, p43-induced hyperphosphorylation of IB␣ stimulated transcription of the adhesion molecules E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1, as well as tissue factor ( Figure 6B ). p43-treated HUVECs showed elevated levels of E-selectin, as determined by immunocytochemistry ( Figure 6C ).
p43 Does Not Stimulate SMC Death
Previous reports suggested that p43 has proapoptotic potential. 21, 22 Because loss of SMCs is detrimental for the structure of atherosclerotic plaques, we explored the possibility that p43 induced SMC death. Cell culture experiments showed that p43, p43(ARF), and EMAP II were not lethal for SMCs at concentrations up to 1 mol/L (not shown). To evaluate whether cytokines or other proteins released by THP1 cells after treatment with p43 (or derivates) could be lethal for SMCs, THP1 cells were incubated with 1 mol/L p43, p43(ARF), or EMAP II for 6 hours. Thereafter, the THP1 culture medium was added to SMCs, and cells were incubated for 24 hours. SMCs did not undergo cell death in response to the preconditioned medium (not shown).
p43 Is Not a Serum Marker for Coronary Artery Disease
Because p43 may be a useful serum marker, [23] [24] [25] we examined whether p43 levels in serum can predict coronary artery disease. Serum samples from patients with documented coronary artery disease were compared with those of matched healthy controls. The lipid parameters were generally lower in patients, whereas C-reactive protein and troponin I were elevated (Supplemental Table I ). Levels of p43 were not statistically different between both groups.
Discussion
Numerous studies have identified apoptosis as a prominent feature of advanced atherosclerotic plaques. 1, 2 Although this process was originally considered inflammation-neutral or antiinflammatory, recent evidence showed that attraction signals released from apoptotic cells play a crucial role in the timely removal of the apoptotic cell by recruiting fresh phagocytes to the site of dead cells. 3 Moreover, some of these find-me signals can modulate the activation and differentiation state of their target cells and thereby influence the consecutive immune response. In this study, we report over-expression of the attraction signal p43 in advanced human plaques. p43 is a proinflammatory cytokine and chemoattractant of macrophages and polymorphonuclear lymphocytes. 5 According to Behrensdorf et al, 13 the mature cytokine (designated EMAP II) is formed in apoptotic cells by caspase cleavage of the precursor molecule and is released by apoptotic cells to attract leukocytes. Additional evidence in favor of this theory comes from an in situ hybridization study in mouse embryos, showing that p43 mRNA was most abundant at sites of tissue remodeling where many apoptotic cells and macrophages were present. 11 Furthermore, apoptosis induced by ischemia-reperfusion in the kidney coincided with posttranslational processing of p43 and recruitment of inflammatory cells to the reperfused kidney. 26 When apoptosis was inhibited, the maturation of p43 and subsequent inflammation also declined. 26 In analogy with these reports, it is plausible to assume that accumulation of apoptotic cells in advanced human plaques combined with overexpression of p43 could represent an important mechanism for further plaque inflammation. Still, several observations including those in the present study suggest that the link between p43, apoptosis, and inflammation is questionable. First, processing of p43 appears to be a late apoptotic event as compared with poly(ADP-ribose) polymerase cleavage, 11 which makes the release of mature p43 as a chemoattractant for leukocytes not logical and even useless. Second, in vitro evidence from the present study indicates that p43 expression parallels protein synthesis. This is not surprising because p43 turned out to be identical to the p43 subunit of the aminoacyl tRNA synthetase complex. 6 Moreover, a comprehensive immunohistochemical survey of p43 expression in human tissues showed that the protein is associated with tissues that display high Figure 5 . Production of proinflammatory proteins in THP1 cells and chemotaxis after stimulation with p43. Cells were exposed to 100 nM recombinant p43, p43(ARF), or EMAP II for 2 hours followed by Western blot analysis of IB␣ and phosphorylated IB␣ (A) and real-time RT-PCR of cytokines (TNF␣, IL1␤, IL8) and chemokines (MIP1␣, MIP1␤, MIP2␣); *PϽ0.05, **PϽ0.01 versus control (1 sample t test, nϭ5) (B). Enhanced secretion of TNF␣ and MIP1␣ in the culture medium was confirmed by ELISA after incubation with 100 nM p43, p43(ARF), or EMAP II for 24 hours; **PϽ0.01 versus control (1-way ANOVA, followed by Dunnett test, nϭ5) (C). Migration of THP1 cells through a transwell was determined after 4 hours incubation using 1 mol/L recombinant p43, p43(ARF), EMAP II, or ATP as chemoattractant; **PϽ0.01 versus control (1-way ANOVA, followed by Dunnett test, nϭ6) (D).
turnover or high levels of protein synthesis, such as the secretory epithelial cells of the thyroid, pancreas, and adrenal and salivary glands, as well as neurons and subsets of monocytes/macrophages, 27 which confirms the close association between p43 and protein translation. Given that protein translation is inhibited during apoptosis, we may conclude that the overexpression of p43 in human plaques is not related to cell death but that it reflects the high metabolic activity of many cells in the plaque. A third aspect that questions the involvement of p43 in apoptosis-induced inflammation is its posttranslational processing. Initial studies by Behrensdorf et al 13 suggested that mouse p43 is cleaved into mature EMAP II by caspase-7 and, to a lesser extent, by caspase-3. However, we and others 14 demonstrated that human p43 is not a substrate for caspase cleavage. Moreover, we could demonstrate that cleavage of p43 was not apoptosis specific but also occurred after induction of necrosis. Apoptotic and necrotic cells cleaved p43 into a p43 intermediate, previously named p43(ARF), 16 and not EMAP II. This p43 intermediate contains 40 additional N-terminal amino acid residues as compared with EMAP II. Using transwell migration experiments, we were able to show that that the chemotactic activity of p43(ARF), as well as that of p43 and EMAP II, was poor compared with ATP. Nucleotides such as ATP are released in large quantities during cell death, 20 suggesting that the chemotaxis capacity of p43-(fragments), if present at all, does not have any significance after induction of apoptosis or necrotic death. Our results further indicate that p43 but not p43(ARF) or EMAP II acts as an activator of nuclear factor-B. Accordingly, only full-length p43 stimulated THP1 cells to upregulate and secrete cytokines (TNF␣, IL1␤, and IL8) and chemokines (MIP1␣, MIP1␤, and MIP2␣). This finding is consistent with a previous report showing that the active cytokine domain of p43 is located within the first 147 amino acids. 15 Because p43(ARF) and EMAP II start from amino acids 107 and 147, respectively, it is conceivable that only p43 is the real cytokine. Consistent with this finding, p43, but not p43(ARF) and EMAP II, triggered HUVECs to express tissue factor and adhesion molecules such as intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin. A similar observation was recently reported for the latter protein, 16 suggesting that at least some of the effects previously ascribed to EMAP II should be carefully reexamined. Of note, a p43-specific receptor has not yet been characterized, although some functions of EMAP II could be attributed to binding with the chemokine receptor CXCR3. 28 Altogether, the nuclear factor-B activity of p43, leading to activation of endothelial cells and cytokine release by macrophages, is lost during cell death, thereby abolishing a potential risk for plaque inflammation. There are, however, other find-me signals released by apoptotic cells such as ATP that may fulfill a genuine role as chemoattractant, 20 so plaque inflammation after massive induction of apoptosis remains a plausible option. Given the conversion of p43 into p43(ARF) during cell death, efforts were made to characterize the protease responsible for cleavage. Cleavage of p43 is not self-evident because the protein is centrally located within the tRNA multisynthetase complex and thus not easily accessible for proteases. 29 Wolfe et al 30 reported that very little, if any, p43 is present as free polypeptide. Moreover, association of p43 with arginyl-tRNA synthetase or tRNAs prevents proteolytic cleavage. 31 Still, Liu and Schwarz 32 identified a 44 -amino acid spanning region in p43 that is sensitive to proteases such as matrix metalloproteinase 9, elastase, and cathepsin L. Of particular interest is the N-terminal sequence generated by elastase that cleaves p43 within 1 amino acid of the determined p43(ARF) sequence. 16 However, elastase can generate multiple protein fragments 32 and may even fully degrade p43, as shown in the present study. By using a panel of protease inhibitors, calpain 1 was found to process p43 into p43(ARF). Calpains comprise a family of cytoplasmic cysteine proteases that have been implicated in apoptosis. 33 We therefore propose the following scenario: calpains are activated shortly after apoptosis induction, cleave p43, and allow p43(ARF) release. In case of necrotic death, there is a possibility that both p43 and calpains are released by the cell, so p43 cleavage may occur extracellularly. Because only full-length p43 facilitates aminoacylation, cleavage of p43 could be a means to arrest translation in cells undergoing programmed cell death. It remains unclear, however, why p43(ARF) is not further processed into EMAP II. According to Liu and Schwarz, 32 treatment of p43 with cathepsin L yields protein fragments consistent with the molecular mass of EMAP II. Cathepsin L is a lysosomal endopeptidase expressed in most eukaryotic cells. Unlike the precursor forms of other cathepsin members, procathepsin L is secreted from various cells. Because activation of cathepsin L is influenced by cell-cell contact and extracellular matrix, 34 one possibility that may explain the absence of EMAP II in our cell culture models is the lack of an appropriate setting that may lead to cathepsin L activation. Another element that might prevent EMAP II formation is the presence of a lysine and glutamate-rich region (a feature known as a KEKE motif) at the N terminus of p43(ARF) that promotes protein:protein interactions and thus, through binding with other proteins, may block conversion of p43(ARF) into EMAP II. 6 However, some groups reported that this KEKE motif may actually promote EMAP II formation through binding with the proteasome. 31 Further research is certainly required to fully elucidate the mechanism of cleavage of p43 to generate EMAP II. Several reports suggest that EMAP II is an active inducer of apoptosis via upregulation of Fas-associated death domain and concomitant downregulation of Bcl-2. 21, 22 Because SMC apoptosis is harmful for the structure of the plaque, we investigated whether p43 or fragments thereof could induce SMC death. Our results indicated that p43 (or fragments) did not induce SMC death. Interestingly, some studies found elevated levels of p43 or EMAP II in serum samples of patients and proposed that circulating p43/EMAP II is a useful biomarker for several disorders including brain injury and lung cancer. 24, 25 Also during pregnancy, p43 and EMAP II serum levels are increased. 23 However, we were unable to find an association between circulating p43/EMAP II and coronary artery disease, despite elevation of standard markers such as C-reactive protein and troponin.
In conclusion, the attraction signal and proinflammatory cytokine p43 is expressed in human atherosclerotic plaques. Although p43 was also detectable in plaques from ApoEdeficient mice, p43 knockout animals with C57Bl6 background (essential for atherogenesis) die in utero, so the effect of p43 deficiency in mouse plaques could not be investigated in the present study. Nonetheless, it is important to note that p43-null mice are born without serious defects in another genetic background, suggesting that other proteins may take over p43 function. 35 In contrast to previous reports showing caspase-mediated activation of p43 and secretion of the mature proteolytic fragment EMAP II by apoptotic cells, our results indicate that p43 was inactivated during apoptosis by calpains and released as a truncated protein p43(ARF). Given the high levels of apoptosis in advanced plaques and the fact that selective induction of macrophage death gains increasing attention in cardiovascular medicine to stabilize vulnerable lesions, 36 this information is of the utmost importance to avoid further plaque inflammation. Moreover, p43 or derived fragments did not induce apoptosis of SMCs, suggesting that p43 expression is not detrimental for the structure of the plaque. On the contrary, its close association with protein translation indicates that it might serve as a marker for the metabolic activity of plaque cells.
